课题基金 / 基金详情

Regulation of mediator release from human mast cell by extracellular adenosine.

Regulation of mediator release from human mast cell by extracellular adenosine.
细胞外腺苷调节人肥大细胞介质释放。
批准号:
8112683
负责人:
Gregorio Valenzuela Gomez
金额:
$9.62万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-15 至 2013-07-31

项目摘要

项目成果

Gregorio Valenzuela Gomez的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):
英文摘要
DESCRIPTION (provided by applicant): This proposal aims to establish a molecular link between G protein-coupled adenosine receptors (ADORs) and Fce/yRs on mature human mast cells to help explain the impact of adenosine on human allergic diseases such as asthma. Extracellular adenosine (extADO) is a purine nucleoside that when inhaled causes bronchospasm and enhances degranulation of mast cells in human asthmatic (but not in normal) airways. Thus, it is implicated in asthma pathogenesis. Four G protein-coupled adenosine receptors (A1AR, A2aAR, A2bAR and A3AR) have been identified and characterized. However, the ADOR responsible for the effect of extADO on human airway mast cells is not clear, though indirect evidence suggests A2bAR is involved. Two types of human mast cells, MCTC and MCT, have been described. MCTC cells from skin express tryptase, chymase, carboxypeptidase A3 and cathepsin G; whereas MCT cells express tryptase alone and are the predominant type in lung. Our preliminary data reveal that high extADO (10-4 M) inhibits FceRI-mediated degranulation of MCTC (skin) mast cells, whereas low extADO (10-7 M) augments mediator release from the MCT (lung) mast cells. Thus, indicating that extADO differentially regulates mediator release from these distinct types of human mast cells. extADO also augments secretion of IL-13, a Th2 cytokine implicated in asthma pathogenesis, but inhibits production of PGD2, TNF a, GM CSF and IL 6 from MCTC cells and inhibits NF-KB activation. The proposed research will characterize the effect of extADO on mediator release from the MCTC and MCT types of mast cells activated through FceRI and also FcyRlla, an activating IgG receptor recently discovered in this lab to be constitutively expressed on skin MCTC and, possibly, on lung MCT cells, and identify the ADOR(s) responsible for the observed contrasting effects on these two types of human mast cells. Syk kinase and src tyrosine kinases Fyn and Lyn, key regulators of FceRI-dependent degranulation, will be analyzed as targets of ADOR signals in MCTC and MCT mast cells. Repression of NF-KB activation will also be assessed as a general mechanism for IL-13 production. Allergies and asthma are major health concerns in the United States. Understanding the cellular components of these disorders and the molecular mechanisms that regulate these cell types is of prime interest in our efforts to alleviate the personal and societal burdens due to these disorders. (End of Abstract)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of mediator release from human mast cell by extracellular adenosine.
  • 批准号:
    7898598
  • 项目类别:
  • 资助金额:
    $9.44万
  • 财政年份:
    2008
  • 负责人:
    Gregorio Valenzuela Gomez
  • 依托单位:
Regulation of mediator release from human mast cell by extracellular adenosine.
  • 批准号:
    7677275
  • 项目类别:
  • 资助金额:
    $9.26万
  • 财政年份:
    2008
  • 负责人:
    Gregorio Valenzuela Gomez
  • 依托单位:
Regulation of mediator release from human mast cell by extracellular adenosine.
Regulation of mediator release from human mast cell by extracellular adenosine.
  • 批准号:
    8307849
  • 项目类别:
  • 资助金额:
    $1.74万
  • 财政年份:
    2008
  • 负责人:
    Gregorio Valenzuela Gomez
  • 依托单位:
国内基金
海外基金
基于ADK/Adenosine调控DNA甲基化探讨“利湿化瘀通络”法对2型糖尿病肾病足细胞裂孔膜损伤的干预机制研究
  • 批准号:
    82074359
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2020
  • 负责人:
    安晓飞
  • 依托单位:
细胞外腺苷(Adenosine)作为干细胞旁分泌因子的生物学鉴定和功能分析
Adenosine诱导A1/A2AR稳态失衡启动慢性低灌注白质炎性损伤及其机制